CYTOMED THERAPEUTICS LTD (GDTC) Stock Analyst Ratings
NASDAQ:GDTC - Nasdaq - SGXZ17669631 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to GDTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.1. This target is 117.02% above the current price.
GDTC was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GDTC.
In the previous month the buy percentage consensus was at a similar level.
GDTC was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-10 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2024-06-11 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-12-04 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-07-21 | Benchmark | Initiate | Speculative Buy |